Literature DB >> 7725699

Severe Mycoplasma disease--rare or underdiagnosed?

G H Cassell.   

Abstract

Entities:  

Mesh：

Year:  1995        PMID： 7725699      PMCID： PMC1022661     

Source DB:  PubMed          Journal:  West J Med        ISSN： 0093-0415


× No keyword cloud information.
  34 in total

1.  The occurrence and clinical picture of serologically verified Mycoplasma pneumoniae infections with emphasis on central nervous system, cardiac and joint manifestations.

Authors:  A Pönkä
Journal:  Ann Clin Res       Date:  1979

Review 2.  The clinical spectrum of Mycoplasma pneumoniae infections.

Authors:  D P Levine; A M Lerner
Journal:  Med Clin North Am       Date:  1978-09       Impact factor: 5.456

3.  Mycoplasma pneumoniae infection and neurological complications.

Authors:  G E Urquhart
Journal:  Br Med J       Date:  1979-12-08

Review 4.  Mycoplasmas as agents of human disease.

Authors:  G H Cassell; B C Cole
Journal:  N Engl J Med       Date:  1981-01-08       Impact factor: 91.245

5.  Neurological syndromes and mycoplasmal infections.

Authors:  W A Clyde
Journal:  Arch Neurol       Date:  1980-02

6.  Mucocutaneous reactions during Mycoplasma pneumoniae infection.

Authors:  K Lind
Journal:  Lancet       Date:  1978-03-25       Impact factor: 79.321

7.  Mucocutaneous reactions during Mycoplasma pneumoniae infection.

Authors:  P D Griffiths
Journal:  Lancet       Date:  1978-05-06       Impact factor: 79.321

8.  Carditis associated with mycoplasma pneumoniae infection.

Authors:  A Pönkä
Journal:  Acta Med Scand       Date:  1979

9.  Mycoplasma pneumoniae infection associated with affection of the central nervous system.

Authors:  K Lind; H Zoffmann; S O Larsen; O Jessen
Journal:  Acta Med Scand       Date:  1979

10.  Recurrent pneumonia and encephalitis due to Mycoplasma pneumoniae.

Authors:  L G Burman; S Löfgren
Journal:  Scand J Infect Dis       Date:  1979
View more
  6 in total

1.  Surfactant protein A mediates mycoplasmacidal activity of alveolar macrophages by production of peroxynitrite.

Authors:  J Hickman-Davis; J Gibbs-Erwin; J R Lindsey; S Matalon
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

2.  Reactive species mediate inhibition of alveolar type II sodium transport during mycoplasma infection.

Authors:  Judy M Hickman-Davis; Carmel McNicholas-Bevensee; Ian C Davis; He-Ping Ma; Glenda C Davis; Charles A Bosworth; Sadis Matalon
Journal:  Am J Respir Crit Care Med       Date:  2005-10-27       Impact factor: 21.405

3.  More on Mycoplasma pneumoniae pneumonia.

Authors:  L A Cone; V D Jodoin; M Mojarad; D Soto
Journal:  West J Med       Date:  1995-08

Review 4.  Respiratory diseases among U.S. military personnel: countering emerging threats.

Authors:  G C Gray; J D Callahan; A W Hawksworth; C A Fisher; J C Gaydos
Journal:  Emerg Infect Dis       Date:  1999 May-Jun       Impact factor: 6.883

5.  Roles of innate and adaptive immunity in respiratory mycoplasmosis.

Authors:  S C Cartner; J R Lindsey; J Gibbs-Erwin; G H Cassell; J W Simecka
Journal:  Infect Immun       Date:  1998-08       Impact factor: 3.441

6.  Fatal Mycoplasma pneumoniae pneumonia in a previously healthy 18-year-old girl.

Authors:  Florian Daxboeck; Bernhard Eisl; Christofer Burghuber; Mazda Memarsadeghi; Ojan Assadian; Gerold Stanek
Journal:  Wien Klin Wochenschr       Date:  2007       Impact factor: 1.704
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.